UroGen Pharma Ltd Forecast and Stock Analysis
Technical URGN stock analysis for Tuesday May 21, 2019.
|Price to book||USD 3.32|
|Next Earnings Date||2019-08-19|
UroGen Pharma Ltd gained 5.67% in the last trading day ( Tuesday, 21st May 2019 ), rising from $37.24 to $39.35 During day the stock fluctuated 6.51% from a day low at $37.03 to a day high of $39.44. The price has risen in 6 of the last 10 days and is up by 4.82% over the past 2 weeks. Volume fell in the last day by -86 506 shares, and in total, 129 999 shares bought and sold for approximately $5.12 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the URGN stock price was $39.97 and low was $35.52.
- 90 day high was $42.32 and low was $34.61.
- 52 week high for the UroGen Pharma Ltd - $64.09 and low - $34.61.
UroGen Pharma Ltd is the upper part of a wide and horizontal trend and normally this would pose a good selling opportunity, but a break-up through the top trend line at $40.08 will give a strong buy signal and a trend shift may be expected. Given the current horizontal trend you can expect UroGen Pharma Ltd with 90% probability to be traded between $34.65 and $39.56 at the end of this period with 90% probability. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Only positive signals in the chart today. UroGen Pharma Ltd holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $38.49 and $38.08. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday May 20, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.
Relative Strength Index (RSI)
RSI14 is 56 and the stock is currently not being overbought or oversold
Support & Resistance
UroGen Pharma Ltd finds support from accumulated volume at $38.48.
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $2.41 (6.51%) between high and low. For the last week, the stock has had a daily average volatility of 3.88%.
Our recommended stoploss: $37.90 (-3.68%) (This stock has low daily movements and this gives low risk. There is a buy signal from pivot bottom found 1 days ago.)
3.88 %Average volatility
Very Low Low Medium High Very High
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for this stock to perform well in the short-term period. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|URGN $39.35 ($2.11 5.67%)|
URGN is up $2.11 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for URGN based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the URGN analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us